Company Analysis

Kestra Medical Technologies, Ltd. (KMTS)

Nasdaq: KMTS · Surgical & Medical Instruments & Apparatus · Kirkland, WA · filing with the SEC since 2021
Grade5.8
◀ Past 6.4● Present 5.5▶ Future 5.6
3 est.

Filings

70 filings since 2017 beside 117 insider forms · Non-accelerated filer and smaller reporting company and emerging growth company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company and emerging growth company
10-Q Quarterly report for the quarter ending Oct 31, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by Dec 15, 2026
10-K Annual report for the fiscal year ending Apr 30, 2027Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Jul 29, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 45 days after the quarter ended. The proxy statement was last filed Jul 28, 2026.

Filings a yearinsider forms included
5278102
2021202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 2 times in the last 36 months, the newest Jun 6, 2025.SEC letters: 7 in the last 36 months, the newest Dec 1, 2025.
Insider forms 117

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Sep 14, 2026 10-Q Quarterly report Jul 31, 2026
Sep 14, 2026 8-K items 2.02, 9.01 Results released · Current report
Sep 10, 2026 8-K item 5.07 Shareholder vote · Current report Sep 9, 2026
Aug 14, 2026 SCHEDULE 13G/A Large holder update, amended
Jul 28, 2026 ARS Annual report to shareholders Apr 30, 2026
Jul 28, 2026 DEFA14A Extra proxy material
Jul 28, 2026 DEF 14A Proxy statement Sep 9, 2026
Jul 14, 2026 10-K Annual report Apr 30, 2026
Jul 14, 2026 8-K items 1.01, 1.02, 2.02, 2.03, 9.01 Major agreement signed; Major agreement ended; Results released; New debt or obligation taken on · Current report Jul 10, 2026
Apr 8, 2026 SCHEDULE 13G/A Large holder update, amended
Apr 1, 2026 S-3ASR Shelf registration
Mar 18, 2026 S-8 Employee stock plan registration
Mar 17, 2026 10-Q Quarterly report Jan 31, 2026
Mar 17, 2026 8-K items 2.02, 9.01 Results released · Current report
Feb 17, 2026 SCHEDULE 13G/A Large holder update, amended
Feb 17, 2026 SCHEDULE 13G/A Large holder update, amended
Feb 17, 2026 SCHEDULE 13G Large holder notice
Dec 11, 2025 10-Q Quarterly report Oct 31, 2025
Dec 11, 2025 8-K items 2.02, 9.01 Results released · Current report
Dec 4, 2025 8-K items 1.01, 9.01 Major agreement signed · Current report Dec 2, 2025
Dec 3, 2025 424B4 Offering prospectus
Dec 2, 2025 EFFECT Registration effective
Dec 2, 2025 S-1MEF Listing registration, added shares
Dec 1, 2025 CORRESP Reply to the SEC
Dec 1, 2025 CORRESP Reply to the SEC
Dec 1, 2025 S-1 Listing registration
Dec 1, 2025 8-K items 2.02, 9.01 Results released · Current report
Nov 10, 2025 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Oct 29, 2025 DRS Draft registration, confidential
Oct 7, 2025 SCHEDULE 13G/A Large holder update, amended
Sep 12, 2025 10-Q Quarterly report Jul 31, 2025
Sep 11, 2025 8-K items 2.02, 9.01 Results released · Current report
Sep 4, 2025 8-K item 5.07 Shareholder vote · Current report Sep 3, 2025
Jul 22, 2025 ARS Annual report to shareholders Apr 30, 2025
Jul 22, 2025 DEFA14A Extra proxy material
Jul 22, 2025 DEF 14A Proxy statement Sep 3, 2025
Jul 17, 2025 10-K Annual report Apr 30, 2025
Jul 15, 2025 8-K items 2.02, 9.01 Results released · Current report
Jun 6, 2025 8-K items 5.02, 9.01 Officer or director change · Current report Jun 4, 2025
May 15, 2025 SCHEDULE 13G Large holder notice
40 of 70 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton KMTS · research, not advice